Why Market Size Forecasters?
- Reports at Lowest Prices - Guaranteed
- Fastest Growing Research Reports’ Database
- Easy Customization Options
- 24 X 7 Support Commitment
- Certified, Safe & Secured Payments
About Assisted Reproductive Technology in Fertility Clinics Infertility is a medical condition that affects both men and women. Generally, a couple is considered infertile when they are unable to conceive after a 12-month period of unprotected sexual intercourse. ART consists of a wide range of procedures that are used to treat infertility in men and women. These procedures are rendered to patients primarily in clinics, which treat infertility and are collectively referred to as fertility clinics. Technavio?s analysts forecast the global assisted reproductive technology market in fertility clinics to grow at a CAGR of 4.36% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global assisted reproductive technology market in fertility clinics for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of ART solutions specifically to fertility clinics. The market is divided into the following segments based on geography: ? Americas ? APAC ? EMEA Technavio's report, Global Assisted Reproductive Technology Market in Fertility Clinics 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Key vendors ? CooperSurgical ? EMD Serono ? Ferring Pharmaceuticals ? Irvine Scientific ? Vitrolife Other prominent vendors ? Anecova ? Cook Medical ? CRITEX ? Esco Micro ? Genea ? IHMedical ? IKS International ? INVO Bioscience ? IVFtech ? Kitazato ? Pantec Biosolutions ? Smiths Medical Market driver ? Growing awareness about ART procedures ? For a full, detailed list, view our report Market challenge ? Limited insurance coverage and improper regulatory oversight ? For a full, detailed list, view our report Market trend ? Emergence of digital innovations ? For a full, detailed list, view our report Key questions answered in this report ? What will the market size be in 2021 and what will the growth rate be? ? What are the key market trends? ? What is driving this market? ? What are the challenges to market growth? ? Who are the key vendors in this market space? You can request one free hour of our analyst?s time when you purchase this market report. Details are provided within the report.
Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: INTRODUCTION ? Market outline PART 05: MARKET LANDSCAPE ? Market overview ? Market size and forecast ? Five forces analysis PART 06: MARKET SEGMENTATION BY PATIENT TYPE ? Segmentation by patient type ? Comparison by patient type ? Global ART market in fertility clinics by female infertility treatment ? Global ART market in fertility clinics by male infertility treatment ? Market opportunity by patient type PART 07: REGIONAL LANDSCAPE ? Geographical segmentation ? Regional comparison ? ART market in fertility clinics in EMEA ? ART market in fertility clinics in Americas ? ART market in fertility clinics in APAC ? Market opportunity PART 08: DECISION FRAMEWORK PART 09: DRIVERS AND CHALLENGES ? Market drivers ? Market challenges PART 10: MARKET TRENDS ? Emergence of digital innovations ? Growing acceptance of same-sex marriages ? Emergence of IVF mega clinics PART 11: VENDOR LANDSCAPE ? Competitive scenario PART 12: VENDOR ANALYSIS ? Vendor overview ? CooperSurgical ? EMD Serono ? Ferring Pharmaceuticals ? Irvine Scientific ? Vitrolife ? Other prominent vendors PART 13: APPENDIX ? List of abbreviations List of Exhibits Exhibit 01: Stages of infertility treatment Exhibit 02: Top IVF clinics around the world Exhibit 03: Global ART market in fertility clinics 2016-2021 ($ billions) Exhibit 04: Five forces analysis Exhibit 05: Global ART market in fertility clinics by patient type 2016-2021 (%) Exhibit 06: Comparison by patient type Exhibit 07: Global ART market in fertility clinics by female infertility treatment 2016-2021 ($ millions) Exhibit 08: Global ART market in fertility clinics by female infertility treatment: Year-over-year growth 2017-2021 (%) Exhibit 09: Global ART market in fertility clinics by male infertility treatment 2016-2021 ($ millions) Exhibit 10: Global ART market in fertility clinics by male infertility treatment: Year-over-year growth 2017-2021 (%) Exhibit 11: Global ART market in fertility clinics by geography 2016-2021 (%) Exhibit 12: Regional comparison Exhibit 13: ART market in fertility clinics in EMEA 2016-2021 ($ billions) Exhibit 14: ART market in fertility clinics in EMEA: Year-over-year growth 2017-2021 (%) Exhibit 15: Top 3 countries in EMEA Exhibit 16: ART market in fertility clinics in Americas 2016-2021 ($ billions) Exhibit 17: ART market in fertility clinics in Americas: Year-over-year growth 2017-2021 (%) Exhibit 18: Top 3 countries in Americas Exhibit 19: ART market in fertility clinics in APAC 2016-2021 ($ billions) Exhibit 20: ART market in fertility clinics in APAC: Year-over-year growth 2017-2021 (%) Exhibit 21: Top 3 countries in APAC Exhibit 22: Types of infertility in males and females Exhibit 23: Global average fertility rate 2010-2015 (births per woman) Exhibit 24: Global average birth rate 2010-2015 (per 1,000 people) Exhibit 25: State-wise obesity prevalence in US Exhibit 26: Obesity prevalence across Europe as percentage of population 2014 Exhibit 27: ART success rate in the US 2002-2014 Exhibit 28: Percentage of geriatric population in Europe 2014-2016 Exhibit 29: Cost breakdown of IVF by various stages in US Exhibit 30: Top mobile applications improving infertility awareness Exhibit 31: Same-sex couples in Canada 2001-2016 (%) Exhibit 32: Global ART market in fertility clinics: Competitive parameters Exhibit 33: Strategic success factors of consideration for companies Exhibit 34: CooperSurgical: Profile Exhibit 35: CooperSurgical: Strength analysis Exhibit 36: CooperSurgical: Strategy assessment Exhibit 37: CooperSurgical: Opportunity assessment Exhibit 38: EMD Serono: Profile Exhibit 39: EMD Serono: Strength analysis Exhibit 40: EMD Serono: Strategy assessment Exhibit 41: EMD Serono: Opportunity assessment Exhibit 42: Ferring Pharmaceuticals: Profile Exhibit 43: Ferring Pharmaceuticals: Strength analysis Exhibit 44: Ferring Pharmaceuticals: Strategy assessment Exhibit 45: Ferring Pharmaceuticals: Opportunity assessment Exhibit 46: Irvine Scientific: Profile Exhibit 47: Irvine Scientific: Strength analysis Exhibit 48: Irvine Scientific: Strategy assessment Exhibit 49: Irvine Scientific: Opportunity assessment Exhibit 50: Vitrolife: Profile Exhibit 51: Vitrolife: Strength analysis Exhibit 52: Vitrolife: Strategy assessment Exhibit 53: Vitrolife: Opportunity assessment
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary research - Manufacturers/Suppliers, Channel partners, Industry experts, Strategic decision makers
Secondary research - Technavio internal repository, Industry journals and periodicals, Government bodies, Annual reports of key stakeholders
Data synthesis - Collation of data, Estimation of key figure, Analysis of derived insights
Data validation - Triangulation with data models, Reference against proprietary databases, Corroboration with industry experts
Qualitative analysis - Market drivers, Market challenges, Market trends, Five forces analysis
Quantitative analysis- Market size and forecast, Market segmentation, Geographical insights, Competitive landscape
Technavio’s database and industry-specific repositories are used for defining the hypothesis for the study, which is further fine-tuned through primary research involving industry experts. The success of our approach lies in the fact that we take the viewpoint of all stakeholders into consideration while analyzing an industry, and objectively assess each outlook.
Why Market Size Forecasters?